Accord UK leading the conversation on how biosimilars can improve access to effective cancer treatments

Cancer is one of the biggest global healthcare challenges facing clinicians today. The rising cost of treatments can affect patients’ access to affordable, effective treatments.

Accord Healthcare is dedicated to improving the lives of patients, both in the UK and across the world, through their generics and biosimilar portfolio.  Accord have been engaging with healthcare professionals and NHS commissioners at two key events to start the conversation on the role that biosimilars can play in increasing access to effective, affordable cancer medicines.

Read More


Accord Healthcare are proud supporters of IHP

Millions of people around the world are suffering because they have little or no access to medicine and health care. They live in communities made vulnerable by conflict, displacement or natural disasters.

The main focus of International Health Partners (IHP) is to stop the suffering caused by poor access to medicine; they help people in hard-to-reach, vulnerable and disaster-hit communities get better access to medicine by overseeing, coordinating and delivering strategic medical product donations.

Read More


Accord acts differently to plot a path towards further growth

James Burt, EVP EMENA and Paul Tredwell, VP Specialty Brands met with Aidan Fry from Generics Bulletin to talk about Accord’s continued rise across Europe in hospital and retail generics and their exciting new developments in added-value products, including biosimilars.

Read More


Accord Healthcare - the most recognised company at the Global Generics & Biosimilar Awards 2018

We are delighted to announce that Accord Healthcare was the most recognised company at the Global Generics & Biosimilar Awards 2018, having won awards for: Company of the Year and Biosimilar Initiative of the Year.  As well, Intas & Accord Healthcare also picked up the award for Company of the Year Asia-Pacific.

Read More


UK generic medicine price flux? – the real data behind the headlines

In 2017, the UK generic medicines market experienced an uncharacteristic amount of volatility creating a number of headlines in the pharmacy trade and mainstream media around the pricing and supply of generic medicines. 

Read More


Accord UK wins ‘Innovation in the Generics market’ at Pharmacy Business Awards

We were delighted to win the award for ‘Innovation in the Generics market’ at the prestigious Pharmacy Business awards with Methofill®. This award recognises the positive contributions made by innovations in the generics market and topped off a great night at the awards ceremony.

Read More


Headline sponsors of the Pharmacy Business Awards

Once again we are the proud headline sponsors of the Pharmacy Business awards in London.

Read More


Barnstaple’s first community landing site for Devon Air Ambulance opened at Accord UK

Accord UK officially opened Barnstaple’s first ever community landing site at its Barnstaple factory for Devon Air Ambulance (DAA).

Read More


Accord Healthcare’s (Intas) Pelgraz® (pegfilgrastim) Given Green Light by CHMP

Pelgraz - a pegylated G-CSF Biosimilar, is latest addition to Accord Healthcare's established portfolio of over 30 oncology treatments across Europe 

Read More

Media Contact:

For all Accord news and media contact information please contact [email protected]